CL2017002668A1 - Tratamiento de infecciones bacterianas en la acuicultura - Google Patents

Tratamiento de infecciones bacterianas en la acuicultura

Info

Publication number
CL2017002668A1
CL2017002668A1 CL2017002668A CL2017002668A CL2017002668A1 CL 2017002668 A1 CL2017002668 A1 CL 2017002668A1 CL 2017002668 A CL2017002668 A CL 2017002668A CL 2017002668 A CL2017002668 A CL 2017002668A CL 2017002668 A1 CL2017002668 A1 CL 2017002668A1
Authority
CL
Chile
Prior art keywords
crustaceans
fish
aquaculture
lisogenic
bacteriophagus
Prior art date
Application number
CL2017002668A
Other languages
English (en)
Inventor
Michael Mattey
Original Assignee
Basf New Business Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf New Business Gmbh filed Critical Basf New Business Gmbh
Publication of CL2017002668A1 publication Critical patent/CL2017002668A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

UNA COMPOSICIÓN COMPRENDE UN BACTERIÓFAGO UNIDO COVALENTEMENTE A UNA PARTÍCULA COMESTIBLE Y SE USA PARA EL TRATAR UNA INFECCIÓN BACTERIANA EN PECES O CRUSTÁCEOS. SE PUEDEN TRATAR INFECCIONES EN PECES O CRUSTÁCEOS CAUSADAS POR ESPECIES BACTERIANAS DE VIBRIO, AEROMONAS, YERSINIA, MORITELLA, RICKETTSIA, PISCIRICKETTSIA, LACTOCOCCUS, PSEUDOMONAS, FLAVOBACTERIUM O PHOTOBACTERIUM. LAS BACTERIAS INFECTADAS CON UN BACTERIÓFAGO LISOGÉNICO SE USAN PARA TRATAR ENFERMEDADES DE PECES O CRUSTÁCEOS CAUSADAS POR INFECCIONES SIMILARES POR BACTERIAS QUE TRANSPORTAN BACTERIÓFAGOS LISOGÉNICOS QUE EXPRESAN UN GEN DE LA TOXINA.
CL2017002668A 2015-04-20 2017-10-19 Tratamiento de infecciones bacterianas en la acuicultura CL2017002668A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15164343 2015-04-20

Publications (1)

Publication Number Publication Date
CL2017002668A1 true CL2017002668A1 (es) 2019-01-11

Family

ID=52997913

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017002668A CL2017002668A1 (es) 2015-04-20 2017-10-19 Tratamiento de infecciones bacterianas en la acuicultura

Country Status (11)

Country Link
US (1) US10849942B2 (es)
EP (1) EP3285787B8 (es)
KR (1) KR20180016360A (es)
CN (1) CN107743397B (es)
BR (1) BR112017022463B1 (es)
CA (1) CA2983214C (es)
CL (1) CL2017002668A1 (es)
DK (1) DK3285787T3 (es)
ES (1) ES2790635T3 (es)
PT (1) PT3285787T (es)
WO (1) WO2016170013A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL246657B1 (pl) * 2016-04-03 2025-02-24 Proteon Pharmaceuticals Spolka Akcyjna Szczepy bakteriofagów i ich zastosowania
CN109055381B (zh) * 2018-08-08 2021-12-21 江苏海洋大学 用于鳗弧菌特异性识别的ssDNA核酸适配体及筛选与应用
US20220008888A1 (en) * 2018-11-22 2022-01-13 Fixed Phage Limited Production of immobilised bacteriophage
CN112662608B (zh) * 2021-02-04 2022-06-10 集美大学 一株变形假单胞菌exbB基因稳定沉默菌株及应用
CN116790514B (zh) * 2023-04-21 2026-04-28 华东理工大学 新分离的杀香鱼假单胞菌噬菌体、其制备方法及应用
WO2024227014A1 (en) * 2023-04-26 2024-10-31 Organicin Scientific, Inc. Shrimp feed and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209680D0 (en) 2002-04-27 2002-06-05 Univ Strathclyde Immobilisation and stabilisation of bacteriophage
US20070248573A1 (en) * 2004-09-17 2007-10-25 Joseph Sturino Chimeric Bacteriophages, Chimeric Phage-Like Particles, and Chimeric Phage Ghost Particles, Methods for Their Production and Use
MX2007005279A (es) * 2004-11-02 2008-03-11 Gangagen Life Sciences Inc Composiciones de bacteriofagos.
GB0526176D0 (en) 2005-12-22 2006-02-01 Blaze Venture Technologies Ltd Particle binding
CA2840681A1 (en) * 2011-06-30 2013-01-03 Kishore Murthy Location-specific bacterial management
US9504721B2 (en) 2012-06-04 2016-11-29 Ctc Bio, Inc. Bacteriophage and its use for preventing proliferation of pathogenic bacteria
GB201217097D0 (en) * 2012-09-25 2012-11-07 Fixed Phage Ltd Treatment of bacterial infection

Also Published As

Publication number Publication date
CN107743397A (zh) 2018-02-27
BR112017022463A2 (pt) 2018-07-17
PT3285787T (pt) 2020-05-11
KR20180016360A (ko) 2018-02-14
WO2016170013A1 (en) 2016-10-27
ES2790635T3 (es) 2020-10-28
EP3285787B8 (en) 2020-06-17
DK3285787T3 (da) 2020-05-18
CA2983214C (en) 2023-10-17
US20180110812A1 (en) 2018-04-26
EP3285787B1 (en) 2020-02-19
BR112017022463B1 (pt) 2021-10-13
US10849942B2 (en) 2020-12-01
CA2983214A1 (en) 2016-10-27
CN107743397B (zh) 2021-08-24
EP3285787A1 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
Gibello et al. The zoonotic potential of Lactococcus garvieae: An overview on microbiology, epidemiology, virulence factors and relationship with its presence in foods
CY1122191T1 (el) Βακτηριο για χρηση ως προβιοτικο για διατροφικες και ιατρικες εφαρμογες
BR112017022463A2 (pt) tratamento de infecções bacterianas em aquacultura
MX392357B (es) Faecalibacterium prausnitzii y desulfovibrio piger para usarse en el tratamiento o prevencion de diabetes y enfermedades intestinales.
MX2017010710A (es) Composición terapeútica y profiláctica producida por microbiota.
MX2017007148A (es) Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
EP3294761A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF UROPATHOGEN E. COLI
PH12017501146B1 (en) Chemical mitigants in animal feed and feed ingredients
PE20200483A1 (es) Sistema novedoso para el biocontrol de patogenos en sistemas de acuicultura y otros sistemas animales
BR112017008184A2 (pt) composições e linhagem
ECSP20084373A (es) Tiofencarboxamidas sustituidas y análogos de las mismas
MX2018013122A (es) Composiciones y procedimientos para tratar infecciones viricas en gambas.
CY1125009T1 (el) Προβιοτικα βακτηριδια για ιχθεις
MX2017016748A (es) Bacteria lactobacillus rhamnosus para el tratamiento de, por ejemplo, vaginosis bacteriana.
MX2019015198A (es) Tratamiento antimicrobiano de las canales de animales y productos alimenticios.
MX376475B (es) Derivado de polimixina y usos del mismo.
CL2019001275A1 (es) Atenuación de virulencia bacteriana mediante atenuación de transporte de folato bacteriano.
Le et al. Bacteriophages as biocontrol agents in aquaculture
PH12018500772A1 (en) Bird feed and in particular poultry feed, comprising synthetic capsaicinoid derivatives and such feed for prohylactic use or treatment of salmonella infection
Alva-Murillo et al. Effects of sodium octanoate on innate immune response of mammary epithelial cells during Staphylococcus aureus internalization
MX2016009094A (es) Composiciones de heme-haloperoxidasa bioactiva y sus metodos de uso.
CN106029894A8 (zh) 使用具有过表达yajL基因的肠肝菌科细菌生产L‑氨基酸的方法
MX384920B (es) Mejoras en y relacionadas con el tratamiento del agua, en particular para inhibir el crecimiento de microorganismos
NI201800137A (es) Composición alimenticia para camarones de mar o langostino para la prevención de la enfermedad de la necrosis aguda del hepatopáncreas mejor conocida como síndrome de mortalidad temprana (ems) causada por vibrio parahaemolyticus
ECSP17020822A (es) Método para producir probióticos autóctonos con actividad inmunoestimulante y su uso en profilaxis contra flavobacteriosis en salmónidos